SCOPE OF THE CODE OF ETHICS FOR PHARMACEUTICAL MARKETING
SCOPE OF THE CODE OF ETHICS FOR PHARMACEUTICAL MARKETING
This code for pharmaceutical marketing (hereinafter referred to as Code) covers the marketing of medicines (both prescription-only and over-the-counter) and relationships between healthcare professionals and pharmaceutical companies as well as relationships between the pharmaceutical industry and patient organisations. The Code applies to companies engaged in pharmaceutical marketing in Lithuania and to their representatives (hereinafter referred to as companies).
Companies shall be liable for their obligations under the Code even when they contract other parties (e.g. companies providing sales services, consultants, market research companies, advertising agencies) to design, implement and conduct the activities covered by the Code on their behalf. Furthermore, companies must take reasonable steps to ensure that any other parties that they commission to design or implement the activities covered by the Code but which do not act on behalf of the company (e.g. joint ventures, licensees) comply with the Code.
The Code covers all methods of promotion, including but not limited to oral and written promotion activities, co-operation, advertising in specialised journals for healthcare professionals and direct mail advertising, the activities of medical sales representatives (defined in section 17.1), advertising over the Internet and other electronic media using audio and video systems, e.g. films, video recordings, data storage services and the like, as well as the supply of free drug samples, distribution of gifts and hospitality events. The Code also applies to relations between companies and healthcare professionals to govern, including but not limited to, relations emerging from research and contracts (including clinical trial studies, non-interventional studies and advice, as well as consultations).
This code for pharmaceutical marketing (hereinafter referred to as Code) covers the marketing of medicines (both prescription-only and over-the-counter) and relationships between healthcare professionals and pharmaceutical companies as well as relationships between the pharmaceutical industry and patient organisations. The Code applies to companies engaged in pharmaceutical marketing in Lithuania and to their representatives (hereinafter referred to as companies).
Companies shall be liable for their obligations under the Code even when they contract other parties (e.g. companies providing sales services, consultants, market research companies, advertising agencies) to design, implement and conduct the activities covered by the Code on their behalf. Furthermore, companies must take reasonable steps to ensure that any other parties that they commission to design or implement the activities covered by the Code but which do not act on behalf of the company (e.g. joint ventures, licensees) comply with the Code.
The Code covers all methods of promotion, including but not limited to oral and written promotion activities, co-operation, advertising in specialised journals for healthcare professionals and direct mail advertising, the activities of medical sales representatives (defined in section 17.1), advertising over the Internet and other electronic media using audio and video systems, e.g. films, video recordings, data storage services and the like, as well as the supply of free drug samples, distribution of gifts and hospitality events. The Code also applies to relations between companies and healthcare professionals to govern, including but not limited to, relations emerging from research and contracts (including clinical trial studies, non-interventional studies and advice, as well as consultations).